Table 2.
Candidate marker | Action | Clinical results | Reference |
---|---|---|---|
sE-selectin | An adhesion molecule on endothelial cells | Reflection of disease severity | 50,52,53,54,66,67 |
sVCAM-1 | An adhesion molecule on endothelial cells | Not correlated with disease severity | 51,52,54,67 |
sICAM-1 | An adhesion molecule on endothelial cells | Not correlated with disease severity | 52,54 |
TARC/CCL17 | A chemokine that attracts CCR4+ or CCR8+ cells | Reflection of disease severity | 55,56,58,68,69,70,71,72 |
MDC/CCL22 | A chemokine that attracts CCR4+ cells | Reflection of disease severity | 56,57,68,69,72,73 |
CTACK | A chemokine that attracts CCR10+ cells | Reflection of disease severity | 58 |
IL-13 | An inducer of IgE production | Reflection of disease severity | 74 |
IgE | Primes the IgE-mediated allergic reaction | Reflection of disease severity | 32,46,68,71,75 |
No significant result | 29,30,72,76 | ||
ECP | A basic protein located in the eosinophil primary matrix | Reflection of disease severity | 75,77,78,79,80 |
No significant result | 67 | ||
TEC | Eosinophils control mechanisms associated with allergy | Reflection of disease severity | 75,79,81 |
sIL-2R | Expressed by antigen-activated T lymphocytes | Reflection of disease severity | 79,80,81 |
IL-16 | A chemokine that attracts CD4+ cells | Reflection of disease severity | 44,73,75 |
IL-18 | An interferon-γ inducing factor | Reflection of disease severity | 71,82,83 |
BDNF | A peripheral neurotrophin | Reflection of disease severity | 84,85 |
NGF | A potent mediator in neuroinflammatory processes | Reflection of disease severity | 86 |
Positive staining on AD skin only | 87 | ||
No significant result | 88 | ||
Substance P | A neurotransmitter and a neuromodulator | Reflection of disease severity | 86 |
Not correlated with disease severity | 89 | ||
CCL18 | A chemokine that attracts both innate and adaptive immune cells | Reflection of disease severity | 90 |
Significantly decreased after Tx | 72 | ||
MEC/CCL28 | A chemokine that attracts CCR3+, CCR10+ cells | Reflection of disease severity | 91,92 |
PF-4 | A platelet chemokine | Reflection of disease severity | 93,94 |
Beta-TG | A platelet chemokine | Reflection of disease severity | 93,94 |
IL-31 | Associated with skin-homing CLA-positive T cells | Reflection of disease severity | 95 |
CLSP | A modulator of calcium-dependent proteins | Positive relation in AEAD skin | 96 |
Der p-specific IgG4 | A specific IgG molecule for Der p | Reflection of disease severity | 32,33,45,48,49 |
Underlyng bar: studies and results of SIT in AD.
sE-selectin, soluble E-selectin; sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, soluble vascular adhesion molecule-1; TARC, thymus and activation-regulated chemokine; CCL, C-C motif ligand; CCR, chemokine receptor; MDC, macrophage-derived chemokine; CTACK, cutaneous T cell-attracting chemokine; IL-13, interleukin-13; ECP, eosinophil cationic protein; TEC, total eosinophil count; sIL-2R, soluble IL-2 receptor; BNDF, brain-derived neurotrophic factor; NGF, nerve growth factor; Tx, treatment; MEC, mucosa-associated epithelial chemokine; PF-4, platelet factor 4; beta-TG, beta-thromboglobulin; CLA, cutaneous lymphocyte antigen; CLSP, calmodulin-like skin protein; AEAD, acute exacerbated.